Results 271 to 280 of about 1,317,192 (351)

Classification of Platelet‐Activating Anti‐Platelet Factor 4 Disorders

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction The prototypic anti‐platelet factor 4 (PF4) disorder—heparin‐induced thrombocytopenia and thrombosis (HITT)—features immunoglobulin G (IgG) class antibodies that activate platelets, monocytes, and neutrophils in a mainly heparin‐dependent fashion via Fcγ receptor‐dependent cellular activation.
Theodore E. Warkentin
wiley   +1 more source

Thyrotoxicosis-Associated Hypercoagulability Leading to Concurrent Ischemic Stroke and Pulmonary Embolism in Graves' Disease. [PDF]

Cureus
Alghanmi AK, Fahmi Khayat A, Ahmed Alhrkan N, Abdullah Alghamdi A.   +3 more
europepmc   +1 more source

Pulmonary embolism: inpatient and outpatient treatment

, 2014
Г. Е. Гендлин, А. В. Мелехов, G. Storozhakov, E. E. Ryazantseva   +3 more
openalex   +2 more sources

Common Hematologic Emergencies—Acute Promyelocytic Leukemia and Microangiopathic Hemolytic Anemias—A Pivotal Role of Clinical Laboratory

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Hematologic emergencies are urgent health conditions which result in significant mortality and morbidity unless timely therapeutic measures are taken. Therapeutic success depends on their timely and accurate recognition by hematology laboratory services.
Ganna Shestakova, Nicolas Ulrich Edgar, Anton V. Rets   +2 more
wiley   +1 more source

Introduction to Pulmonary Embolism Treatment: An Evolving Paradigm. [PDF]

Interv Cardiol
Montero-Cabezas JM.
europepmc   +1 more source

Development and Validation of a Multivariable Prediction Model Predicts Pulmonary Embolism in Syncope Patients

Dai Meifen, Qiang Jianling, Gang Chen, Wang Maofeng   +3 more
openalex   +1 more source

A Retrospective Study of Adult and Pediatric D‐Dimer Tests to Identify Opportunities for Improved Utilization

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Introduction D‐dimers are produced by lysis of cross‐linked fibrin. In children, D‐dimer testing is used to evaluate disseminated intravascular coagulation (DIC) and some inflammatory states, but its use is not validated for screening or ruling out suspected venous thromboembolic events (VTE).
Rabab Al Dawood, Hassan Abu Sabah, Natalie Mathews, James Douketis, Catherine Hayward   +4 more
wiley   +1 more source

Cerebral Tissue Pulmonary Embolism Masquerading as Primary Graft Dysfunction After Lung Transplantation. [PDF]

Pulm Circ
Izhakian S, Heching M, Fridel L, Rosengarten D, Kramer MR, Shtraichman O.   +5 more
europepmc   +1 more source

Out With the Old, in With the New: Age‐Related D‐Dimer Thresholds

International Journal of Laboratory Hematology, EarlyView.
ABSTRACT Background A fixed D‐dimer cut‐off threshold of 0.500 μg/mL is used in Blackrock Health Hermitage Clinic (BHHC) and most Haematology laboratories across Ireland, however, international guidelines have evolved over the past decade, and a growing body of evidence supports the use of age‐adjusted D‐dimer thresholds.
Ciara O'Connor, Claire McIntyre, Claire Wynne   +2 more
wiley   +1 more source

Evolving Management of Acute Pulmonary Embolism with Extracorporeal Membrane Oxygenation-A Narrative Review. [PDF]

J Clin Med
Hart JP, Davies MG.
europepmc   +1 more source